Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models. (4th November 2015) - Bao, Xingfeng; Albu, Diana; Huang, Kuan-Chun; Wu, Jiayi; Twine, Natalie; Nomoto, Kenichi; Woodall-Jappe, Mary